Home NDC 65597-503 Roxybond
Product NDC 65597-503
11-digit product format 655970503
Labeler code 65597
Product ID 65597-503_eb44aa7a-4db6-42ab-9141-8dbf3742be60
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name oxycodone hydrochloride
Dosage form TABLET, COATED
Route ORAL
Labeler Daiichi Sankyo Inc.
Application NDA209777
Marketing category NDA
Marketing start 2017-04-20
Marketing end 0000-00-00
Substance OXYCODONE HYDROCHLORIDE
Active strength 30 mg/1
Pharmacologic classes Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA schedule CII
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 65597-503-10 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 65597-503-10 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 65597-503-10 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 65597-503-10 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 65597-503-10 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 65597-503-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 65597-503-10 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 65597-503-10 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 65597-503-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 65597-503-10 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 65597-503-10 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 65597-503-10 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209777-001 ROXYBOND OXYCODONE HYDROCHLORIDE 5MG TABLET / ORAL 2017-04-20 N209777-002 ROXYBOND OXYCODONE HYDROCHLORIDE 15MG TABLET / ORAL 2017-04-20 N209777-003 ROXYBOND OXYCODONE HYDROCHLORIDE 30MG TABLET / ORAL 2017-04-20 N209777-004 ROXYBOND OXYCODONE HYDROCHLORIDE 10MG TABLET / ORAL 2024-09-05
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209777-001 10314788 2028-08-12 Drug product 2019-07-10 N209777-001 7955619 2028-08-12 Drug product 2017-05-19 N209777-002 10314788 2028-08-12 Drug product 2019-07-10 N209777-002 7955619 2028-08-12 Drug product 2017-05-19 N209777-003 10314788 2028-08-12 Drug product 2019-07-10 N209777-003 7955619 2028-08-12 Drug product 2017-05-19 N209777-004 10314788 2028-08-12 Drug product 2024-10-04 N209777-004 7955619 2028-08-12 Drug product 2024-10-04
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 141 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209777-002 ROXYBOND 15MG TABLET / ORAL 2017-04-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209777-003 ROXYBOND 30MG TABLET / ORAL 2017-04-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209777-004 ROXYBOND 10MG TABLET / ORAL 2024-09-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209777-002 ROXYBOND 15MG TABLET / ORAL 2017-04-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209777-003 ROXYBOND 30MG TABLET / ORAL 2017-04-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209777-004 ROXYBOND 10MG TABLET / ORAL 2024-09-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209777-002 ROXYBOND 15MG TABLET / ORAL 2017-04-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209777-003 ROXYBOND 30MG TABLET / ORAL 2017-04-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209777-004 ROXYBOND 10MG TABLET / ORAL 2024-09-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-002 ROXYBOND 15MG TABLET / ORAL 2017-04-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-003 ROXYBOND 30MG TABLET / ORAL 2017-04-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-004 ROXYBOND 10MG TABLET / ORAL 2024-09-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209777-002 ROXYBOND 15MG TABLET / ORAL 2017-04-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209777-003 ROXYBOND 30MG TABLET / ORAL 2017-04-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209777-004 ROXYBOND 10MG TABLET / ORAL 2024-09-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209777-002 ROXYBOND 15MG TABLET / ORAL 2017-04-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209777-003 ROXYBOND 30MG TABLET / ORAL 2017-04-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209777-004 ROXYBOND 10MG TABLET / ORAL 2024-09-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209777-002 ROXYBOND 15MG TABLET / ORAL 2017-04-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209777-003 ROXYBOND 30MG TABLET / ORAL 2017-04-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209777-004 ROXYBOND 10MG TABLET / ORAL 2024-09-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209777-002 ROXYBOND 15MG TABLET / ORAL 2017-04-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209777-003 ROXYBOND 30MG TABLET / ORAL 2017-04-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209777-004 ROXYBOND 10MG TABLET / ORAL 2024-09-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209777-002 ROXYBOND 15MG TABLET / ORAL 2017-04-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209777-003 ROXYBOND 30MG TABLET / ORAL 2017-04-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209777-004 ROXYBOND 10MG TABLET / ORAL 2024-09-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209777-002 ROXYBOND 15MG TABLET / ORAL 2017-04-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209777-003 ROXYBOND 30MG TABLET / ORAL 2017-04-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209777-001 ROXYBOND 5MG TABLET / ORAL 2017-04-20 d8e5a09893c0…
Observed Orange Book patent history# Patent history page 1 of 8 · 282 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N209777-001 10314788 2028-08-12 Drug product 2019-07-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209777-001 7955619 2028-08-12 Drug product 2017-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209777-002 10314788 2028-08-12 Drug product 2019-07-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209777-002 7955619 2028-08-12 Drug product 2017-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209777-003 10314788 2028-08-12 Drug product 2019-07-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209777-003 7955619 2028-08-12 Drug product 2017-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209777-004 10314788 2028-08-12 Drug product 2024-10-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209777-004 7955619 2028-08-12 Drug product 2024-10-04 84e616aacf4f…2026-08-18 06:07:40 2026-07 N209777-001 10314788 2028-08-12 Drug product 2019-07-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209777-001 7955619 2028-08-12 Drug product 2017-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209777-002 10314788 2028-08-12 Drug product 2019-07-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209777-002 7955619 2028-08-12 Drug product 2017-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209777-003 10314788 2028-08-12 Drug product 2019-07-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209777-003 7955619 2028-08-12 Drug product 2017-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209777-004 10314788 2028-08-12 Drug product 2024-10-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209777-004 7955619 2028-08-12 Drug product 2024-10-04 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209777-001 10314788 2028-08-12 Drug product 2019-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209777-001 7955619 2028-08-12 Drug product 2017-05-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209777-002 10314788 2028-08-12 Drug product 2019-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209777-002 7955619 2028-08-12 Drug product 2017-05-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209777-003 10314788 2028-08-12 Drug product 2019-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209777-003 7955619 2028-08-12 Drug product 2017-05-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209777-004 10314788 2028-08-12 Drug product 2024-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209777-004 7955619 2028-08-12 Drug product 2024-10-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-001 10314788 2028-08-12 Drug product 2019-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-001 7955619 2028-08-12 Drug product 2017-05-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-002 10314788 2028-08-12 Drug product 2019-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-002 7955619 2028-08-12 Drug product 2017-05-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-003 10314788 2028-08-12 Drug product 2019-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-003 7955619 2028-08-12 Drug product 2017-05-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-004 10314788 2028-08-12 Drug product 2024-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209777-004 7955619 2028-08-12 Drug product 2024-10-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209777-001 10314788 2028-08-12 Drug product 2019-07-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209777-001 7955619 2028-08-12 Drug product 2017-05-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209777-002 10314788 2028-08-12 Drug product 2019-07-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209777-002 7955619 2028-08-12 Drug product 2017-05-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209777-003 10314788 2028-08-12 Drug product 2019-07-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209777-003 7955619 2028-08-12 Drug product 2017-05-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209777-004 10314788 2028-08-12 Drug product 2024-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209777-004 7955619 2028-08-12 Drug product 2024-10-04 6a471c1ec25d…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join RoxyBond OXYCODONE HYDROCHLORIDE Protega Pharmaceuticals Inc 72398542-8e0a-47b2-afeb-9ca5a1f15083 2026-01-13 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 209777 application number: NDA209777